Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS)

Published:2014-05 Issue:3 Volume:3 Page:355-363
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Khatri B.O.,Pelletier J.,Kappos L.,Hartung H.-P.,Comi G.,Barkhof F.,von Rosenstiel P.,Meng X.,Grinspan A.,Hashmonay R.,Cohen J.A.

Funder

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference22 articles.

1. Clinical course after change of immunomodulating therapy in relapsing–remitting multiple sclerosis;Caon;Eur J Neurol,2006

2. Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing–remitting multiple sclerosis in Argentina;Carra;Eur J Neurol,2008

3. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis;Cohen;N Engl J Med,2010

4. Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS;Cohen;J Neurol,2013

5. Early treatment of multiple sclerosis to prevent neurologic damage;Coyle;Neurology,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-01-04

2. Are different degrees of lymphopenia for FTY720 associated with serious infectious-type events? No;Revista Mexicana de Neurociencia;2022-05-17

3. Combined Use of Magnesium Sulfate and Fingolimod for Antenatal Neuroprotection against Inflammation-Mediated Experimental Preterm Brain Injury in a Rat Model;Fetal and Pediatric Pathology;2021-06-30

4. Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis;Drugs;2021-05-13

5. Immunohistochemical analysis of protective effects of maternal fingolimod on the placenta and fetal lung and brain in chorioamnionitis-induced preterm birth rat model;Immunopharmacology and Immunotoxicology;2020-09-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3